NEWS
ARQUIMEA Group boosts an alliance of biotech companies and molecular and genetic diagnosis labs from all over Spain to launch a COVID-19 detection service based on the qPCR technique
Alianza COVID-19’s objective is to gather and coordinate all the resources available in the Spanish private sector in order to make realiable COVID-19 diagnosis and contributing to the huge test demand that exists in the country.
The Island Council of Tenerife kickstarts Nanotec park with the settling of ARQUIMEA Group
The island’s Innovation Counsellor, Enrique Arriaga, underlines the creation of up to 150 highly-qualified job posts for the research center in the island, as well as the objective of attracting first-level technology companies to Tenerife.
ARQUIMEA REACTs successfully complete a synchronized release in the first flight test of ALTAIR project
ALTAIR (Air Launch space Transportation using an Automated aircraft and an Innovative Rocket) is a European H2020 project coordinated by ONERA, involving partners from six countries and aiming to develop and validate a cost-effective and reliable space launch system based on an unmanned aircraft carrier releasing a micro-launcher for small satellite access to LEO.

ARQUIMEA Research Center, Kaudal and the Universidad Europea de Canarias promote the development of R+D projects


ARQUIMEA Group boosts an alliance of biotech companies and molecular and genetic diagnosis labs from all over Spain to launch a COVID-19 detection service based on the qPCR technique


The Island Council of Tenerife kickstarts Nanotec park with the settling of ARQUIMEA Group


ARQUIMEA REACTs successfully complete a synchronized release in the first flight test of ALTAIR project
